Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children

Abstract

To investigate antibiotic resistance among pathogens isolated from urines in a tertiary care children’s hospital in Italy. Retrospective analysis of prospectively collected data on antibiotic susceptibility of Gram-negatives isolated from urines at the Istituto Giannina Gaslini, Genoa - Italy from 2007 to 2014. Antibiotic susceptibility was evaluated. By means of CLSI criteria from 2007 to 2010, while from 2011 EUCAST criteria were adopted. Data on susceptibility to amoxicillin-clavulanate, co-trimoxazole, cefuroxime, nitrofurantoin, fosfomycin and ciprofloxacin were evaluated for Escherichia coli, while for other Enterobacteriaceae data were collected for amoxicillin-clavulanate, co-trimoxazole and ciprofloxacin and for ciprofloxacin against Pseudomonas aeruginosa. Univariate and multivariable analyses were performed for risk factors associated with resistance. A total of 4596 Gram-negative strains were observed in 3364 patients. A significant increase in the proportion of resistant strains was observed for E.coli against amoxicillin-clavulanate, cefuroxime and ciprofloxacin and for others Enterobacteriaceae against co-trimoxazole and ciprofloxacin. Resistance to nitrofurantoin and fosfomycin was very infrequent in E.coli. Logistic regression analysis showed that repeated episode of urinary tract infections was a risk factor for E.coli resistance to amoxicillin-clavulanate, co-trimoxazole and cefuroxime, while admission in one of the Units usually managing children with urinary tract malformations was significantly associated to resistance to amoxicillin-clavulanate and cefuroxime.

Conclusion: In conclusion the present study shows an increase in antibiotic resistance in pediatric bacteria isolated from urines in children, especially in presence of repeated episodes and/or urinary tract malformations. This resistance is worrisome for beta-lactams and cotrimoxazole, and start to increase also for fluoroquinolones while nitrofurantoin and fosfomycin still could represent useful drugs for oral treatment of these infections.

What is Known:
Infections are frequent in patients with urinary tract malformations
Antibiotic prophylaxis can select for resistant pathogens
What is New:
• The increase in the resistance to β-lactams, co-trimoxazole or fluoroquinolones in pathogens causing urinary tract infections cause a reduction of drugs with oral formulations available for therapy
Old drugs like nitrofurantoin and fosfomycin can represent attractive compounds for oral treatment of urinary tract infections in children presence of resistance to other drug classes

This is a preview of subscription content, log in to check access.

Abbreviations

AMC:

amoxicillin-clavulanate

CFU:

colony forming units

CIP:

ciprofloxacin

CI:

confidence intervals

CLSI:

Clinical and Laboratory Standard Institute

CRM:

cefuroxime

ECDC:

European Centre for Disease Prevention and Control

EUCAST:

European Committee on Antimicrobial Susceptibility Testing

FN:

nitrofurantoin

FOS:

fosfomycin

IGG:

Istituto Giannina Gaslini, Genoa – Italy

OR:

odds ratios

SD:

standard deviation

SXT:

co-trimoxazole

UTIs:

urinary tract infections

References

  1. 1.

    Becknell B, Schober M, Korbel L, Spencer JD (2015) The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti-Infect Ther 13:81–90

  2. 2.

    Liu JJ, Dairiki Shortliffe LM (2012) Genitourinary tract infections. In: Long S, Pickering LK, Prober CG (eds) Principles and practice of pediatric infectious diseases. Elsevier, London, pp. 339–343

  3. 3.

    European Centre for Disease Prevention and Control (2014) Antimicrobial resistance surveillance in Europe 2013. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf ECDC, Stockholm. Accessed 1 April 2015

  4. 4.

    National Institute for Clinical Excellence (2016) Urinary tract infection in children overview http://pathways.nice.org.uk/pathways/urinary-tract-infection-in-children. Accessed 21 January 2016

  5. 5.

    The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. http://www.eucast.org

  6. 6.

    Bitsori M, Maraki S, Galanakis E (2014) Long-term resistance trends of uropathogens and association with antimicrobial prophylaxis. Pediatr Nephrol 29:1053–1058

  7. 7.

    European Centre for Disease Prevention and Control (2013) Antimicrobial resistance interactive database: EARS-Net http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/table_reports.aspx. Accessed 2 April 2015

  8. 8.

    Mirò E, Del Cuerpo M, Navarro F, Sabaté M, Mirelis B, Prats G (1998) Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperptoduction. J Antimicrob Chemother 42:535–538

  9. 9.

    Leclercq R, Canton R, Brown DFJ, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley YG, Kahlmeter G (2013) EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19:141–160

  10. 10.

    Gendrel D, Chalumeau M, Moulin F, Raymond J (2003) Fluoroquinolones in paediatrics: a risk for the patient or for the community? Lancet Infect Dis 3:537–546

  11. 11.

    Tseng MH, Lo WT, Lin WJ, Teng CS, Chu ML, Wang CC (2008) Changing trend in antimicrobial resistance of pediatric uropathogens in Taiwan. Pediatr Int 50:797–800

  12. 12.

    Garraffo A, Marguet C, Checoury A, Boyer S, Gardrat A, Houivet E, Caron F (2014) Urinary tract infections in hospital pediatrics: many previous antibiotherapy and antibiotics resistance, including fluoroquinolones. Med Mal Infect 44:63–68

  13. 13.

    Maraki S, Mantadakis E, Michailidis L, Samonis G (2013) Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010. J Microbiol Immunol Infect 46:202–209

  14. 14.

    Coulthard MG, Lambert HJ, Keir MJ (1997) Occurrence of renal scars in children after their first referral for urinary tract infection. BMJ 315:918–919

  15. 15.

    Zorc JJ, Kiddoo DA, Shaw KN (2005) Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev 18:417–422

  16. 16.

    Arant BS Jr (1991) Vesicoureteric reflux and renal injury. Am J Kidney Dis 17:491–511

  17. 17.

    Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R (2007) Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298:179–186

  18. 18.

    Trial Investigators RIVUR, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA (2014) Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 370:2367–2376

Download references

Authors’ contributions

AC and SG were responsible for data analysis, results interpretation and for writing manuscript.

IC was responsible for data collection.

MGC was responsible for statistical analysis.

GL was responsible for data collection and analysis.

GP was responsible for data collection and analysis.

RB was responsible for study design, data collection and analysis.

EC was responsible for study design, results interpretation and supervising work and approved the final manuscript as submitted.

Author information

Correspondence to Elio Castagnola.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Funding

This project was done with no specific support or funds.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Anna Calzi and Sara Grignolo are shared first authors.

Revisions received: 16 June 2016; 28 July 2016

Communicated by David Nadal

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Calzi, A., Grignolo, S., Caviglia, I. et al. Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children. Eur J Pediatr 175, 1219–1225 (2016). https://doi.org/10.1007/s00431-016-2763-1

Download citation

Keywords

  • Oral antibiotics
  • Gram-negative rods
  • Urinary tract infection
  • Children